Position in ARDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,589,133
-$20,660,631 QoQ
Shares Held
1,600,857
-69.1% QoQ
Ownership
0.648%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. ARDX ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in ARDX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,589,133 | 1,600,857 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $30,249,764 | 5,188,639 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $49,276,160 | 8,943,042 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $44,102,555 | 11,250,652 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $41,164,501 | 8,383,809 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $582,132 | 114,819 | Shares | Other | 2025-02-13 | |
| 2024-03-31 | $1,974,401 | 270,466 | Shares | Other | 2024-05-15 | |
| 2023-03-31 | $312,470 | 65,234 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $2,118,709 | 743,407 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $133,042 | 111,800 | Shares | Other | 2022-11-14 | |
| 2021-03-31 | $20,573,205 | 3,107,735 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $21,269,937 | 3,287,471 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $17,244,386 | 3,284,645 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $22,893,609 | 3,308,325 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $18,951,555 | 3,333,607 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||